Study on the Long-Term Risk of Recurrence of Anoperineal Fistula in Crohn's Disease
Study on the Long-Term Risk of Recurrence of Anoperineal Fistula After Treatment with Anti-tumor Necrosis Factor (TNF) and Seton Drainage in Crohn's Disease : LT-SAFCD
University Hospital, Toulouse
81 participants
Sep 17, 2024
OBSERVATIONAL
Conditions
Summary
This research aims to evaluate the long-term recurrence risk of perianal fistulas in Crohn's disease patients who have undergone treatment with anti-TNF therapy and seton drainage.The research seeks to identify factors influencing recurrence and assess the long term effectiveness of these treatments in preventing fistula recurrence. This study will provide insights that could enhance treatment strategies and improve patient outcomes.
Eligibility
Inclusion Criteria3
- Confirmed diagnosis of Crohn's disease
- drainage of an anal fistula with seton combined with the initiation of anti-TNF alpha treatment
- Patient who was treated in the digestive center of the Toulouse University Hospital for drainage of an anal fistula between January 1, 2000 and December 31, 2010
Exclusion Criteria1
- Patient followed less than 6 months after seton drainage
Interventions
Crohn's disease patients who have undergone treatment with anti-TNF therapy and seton drainage.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06514092